Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MS21570 作为 GPR171 拮抗剂基于其阻断能力,IC50 为 220 nM,可减少小鼠的焦虑样行为和恐惧条件反射。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 198 | 现货 | ||
5 mg | ¥ 463 | 现货 | ||
10 mg | ¥ 747 | 现货 | ||
25 mg | ¥ 1,330 | 现货 | ||
50 mg | ¥ 2,230 | 现货 | ||
100 mg | ¥ 3,820 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 822 | 现货 |
产品描述 | MS21570 as a GPR171 antagonist based on its ability to block,with an IC50 of 220 Nm,that reduces anxiety-like behavior and fear conditioning in mice. |
靶点活性 | GPR171:220 nM |
体内活性 | The role of GPR171 in anxiety-like behavior or fear conditioning was evaluated following systemic or intra-BLA administration of MS21570, as well as following lentiviral-mediated knockdown of GPR171 in the BLA.?Systemic administration of MS21570 attenuates anxiety-like behavior while intra-BLA administration or knockdown of GPR171 in the BLA reduces anxiety-like behavior and fear conditioning. |
动物实验 | Mice were habituated to the testing room 1?h prior to each experiment.?Behaviors were videotaped and analyzed using Noldus EthoVision XT or by an experimenter blinded to the treatment groups.?Mice were injected with MS21570 (5?mg/kg) 15?min prior to elevated plus maze, open field, forced swim, and contextual fear conditioning.?For microinjection studies, MS21570 was injected 10?min prior to testing and immediately following the contextual fear conditioning.?A counterbalanced within-subjects design was used when appropriate (battery of anxiety tests). |
别名 | 5-(苄基硫代)-N-甲基-1,3,4-噻二唑-2-胺 |
分子量 | 237.34 |
分子式 | C10H11N3S2 |
CAS No. | 65373-29-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (526.67 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.2134 mL | 21.0668 mL | 42.1336 mL | 105.3341 mL |
5 mM | 0.8427 mL | 4.2134 mL | 8.4267 mL | 21.0668 mL | |
10 mM | 0.4213 mL | 2.1067 mL | 4.2134 mL | 10.5334 mL | |
20 mM | 0.2107 mL | 1.0533 mL | 2.1067 mL | 5.2667 mL | |
50 mM | 0.0843 mL | 0.4213 mL | 0.8427 mL | 2.1067 mL | |
100 mM | 0.0421 mL | 0.2107 mL | 0.4213 mL | 1.0533 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
MS21570 65373-29-7 Endocrinology/Hormones GPCR/G Protein GPR Inhibitor 5-(苄基硫代)-N-甲基-1,3,4-噻二唑-2-胺 inhibit MS 21570 MS-21570 inhibitor